The 5000 Compact Series Ultrasound Systems

The Philips 5000 Compact Series Ultrasound Systems are Class II diagnostic devices designed for comprehensive diagnostic ultrasound imaging and fluid flow analysis across various clinical applications. Their advanced functionality is enhanced by the Auto Measure Version 2 software, an AI-machine learning algorithm that semi-automates echocardiography measurements, validated for accuracy against manual methods to improve diagnostic efficiency.

Philips Ultrasound LLC's 5000 Compact Series Ultrasound Systems, classified as Class II diagnostic devices, have received a determination of substantial equivalence, enabling their marketing for diagnostic ultrasound imaging and fluid flow analysis. These systems are designed for diverse clinical applications including abdominal, cardiac, vascular, fetal, musculoskeletal, and urology, and are intended for use in various medical environments such as physicians' offices, clinics, hospitals, and surgical suites. This regulatory approval signifies their alignment with existing legally marketed devices. A key enhancement to the 5000 Compact Series is the integration of Auto Measure Version 2, an artificial intelligence-machine learning algorithm. This feature provides semi-automated and editable measurements specifically for echocardiography, allowing users to interactively manage the system's suggestions. The safety and effectiveness of the device, including this AI-powered functionality, were affirmed through adherence to internal processes and compliance with recognized standards for medical device software and risk management. Performance data demonstrated that the accuracy of automated measurements closely matches that of manual measurements, validating the system's utility and reliability.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific types of errors or outliers, if any, were observed in the Auto Measure Version 2's automated measurements compared to manual measurements, and how are these addressed clinically?; How does the integration of Auto Measure Version 2 impact the overall workflow efficiency and diagnostic throughput in high-volume echocardiography settings?; What is the algorithm's performance in challenging or atypical echocardiography cases, such as those with poor image quality or complex pathologies?; What ongoing validation or post-market surveillance mechanisms are in place to monitor the long-term safety and effectiveness of the AI-powered features, especially as the algorithm learns or is updated?; Beyond echocardiography, are there plans to extend the Auto Measure Version 2 functionality to other diagnostic applications supported by the 5000 Compact Series Ultrasound Systems?